Opposition · USPTO

Opposition 91310257

PendingUSPTO

Opposition 91310257 at USPTO between MacuHealth Limited Partnership and Bausch & Lomb Incorporated, over the mark PRESERVISION AREDS3, filed Sep 9, 2026. Status in the office record: pending.

View PRESERVISION AREDS3Get this data via the API
Status
Pending
Filed
Sep 9, 2026
Marks involved
3
Parties

Who is involved

The parties as named in the office record.

Opponent

MacuHealth Limited Partnership

Respondent

Bausch & Lomb Incorporated

Company trademarks
Timeline

How the case has moved

Dates from the USPTO record and the PRESERVISION AREDS3 filing.

  1. PRESERVISION AREDS3 filed

    Application 99094097 filed at the USPTO.

  2. Opposition filed

    MacuHealth Limited Partnership started opposition 91310257 at USPTO against PRESERVISION AREDS3.
  3. Next

    Awaiting decision

    No decision is recorded at USPTO yet.
Marks

Marks involved

3 contested marks.

MarkRoleApplicationOffice
PRESERVISION AREDS3Contested99094097USPTO
BAUSCH + LOMB PRESERVISION AREDS3Contested99094159USPTO
BAUSCH + LOMB PRESERVISION EYE VITAMIN AND MINERAL SUPPLEMENT AREDS3 FORMULAContested99094508USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_17e4650b-b809-4d5d-ad09-00b8c5a4cc3e
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_17e4650b-b809-4d5d-ad09-00b8c5a4cc3e",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91310257",
  "status": "pending",
  "office_code": "US",
  "filed_date": "2026-09-09",
  "parties": [
    {
      "name": "MacuHealth Limited Partnership",
      "role": "opponent"
    },
    {
      "name": "Bausch & Lomb Incorporated",
      "role": "respondent"
    }
  ]
}